APRN Pharmacology Today: Goal Attainment And Optimal Treatment For Hypertension
Dr. Joel C. Marrs, PharmD, FCCP, FASHP, FNLA, BCPS-AQ Cardiology, BCACP, CLS, ASH-CHC
This innovative pharmacology course includes case studies, self-assessment quizzes, and reflection to engage and illustrate pharmacotherapy contexts for hypertension, along with information on available drug treatments, current clinical practice guidelines, standards of care, and therapeutic options to minimize hypertensive complications.
Hypertension has doubled, to more than 1.1 billion worldwide, and based on recent estimates, only 50 percent of patients with hypertension are at their blood pressure goal.
Due to the high prevalence of hypertension, continued rise in rates of hypertension, and lack of optimal blood pressure control, APRNs from all practice areas are likely to interact with this patient population. How prepared are you to treat patients with hypertension or those taking antihypertensive medications?
Delve into this new APRN Pharmacology Today course, and discover available drug treatments for hypertension, current clinical practice guidelines, standards of care, and therapeutic options to improve blood pressure control and minimize hypertensive complications. This interactive online course uses the latest evidence-based resources to help you select medications for the treatment of hypertension, focusing on blood pressure goal attainment and optimal treatment selection.
Register now for this online course, and take the first step toward safe prescribing practices.
NOTE: This innovative pharmacology course includes case studies, self-assessment quizzes, and reflection to engage and illustrate pharmacotherapy contexts for hypertension, along with information on available drug treatments, current clinical practice guidelines, standards of care, and therapeutic options to minimize hypertensive complications.
Key Learning Outcomes
- Describe risk factors and diagnostic criteria for hypertension
- Review current literature and guideline recommendations for the treatment of hypertension
- Compare and contrast the available pharmacologic treatments for hypertension
- Formulate a treatment and monitoring plan for a patient with hypertension to decrease the risk of complications in the general population and subpopulations
- And much more!
Dr. Joel C. Marrs
PharmD, FCCP, FASHP, FNLA, BCPS-AQ Cardiology, BCACP, CLS, ASH-CHC
Dr. Joel Marrs is an Associate Professor in the Department of Clinical Pharmacy at the University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS). Dr. Marrs received his PharmD degree from Butler University. Following his PharmD degree, he completed a postgraduate year 1 (PGY1) pharmacy practice residency at Mount Carmel Medical Center in Columbus, Ohio and a PGY2 Family Medicine Specialty residency at the University of Colorado in Denver, Colorado. He is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Cardiology and a Board Certified Ambulatory Care Pharmacist. He is a Clinical Lipid Specialist recognized by the Accreditation Council for Clinical Lipidology. He is an American Society of Hypertension Certified Hypertension Clinician (ASH-CHC). He is Fellow of the American Society of Health-system Pharmacists (ASHP), the National Lipid Association (NLA) and the American College of Clinical Pharmacy (ACCP). Currently, he is president-elect of the Southwest Chapter of the NLA. In his current position, Dr. Marrs practices as a clinical pharmacy specialist with Denver Health in an internal medicine clinic where he focuses on cardiovascular and metabolic pharmacotherapy. His research interests are focused on the prevention and management of endocrine and cardiovascular disease and patient-centered outcomes research. He is the chair of the University of Colorado SSPPS curriculum committee.